STAT+: Hims’ sales miss as telehealth competition grows

Bristol's partnership with Hengrui Pharma, Viiv loses HIV treatment case, and more biotech news from The Readout
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

Bristol's partnership with Hengrui Pharma, Viiv loses HIV treatment case, and more biotech news from The Readout
Source
Stat News
Opens original article in a new tab

The deadliest drug in the country, the new name for PCOS, and more health news from Morning Rounds

In this edition of STAT Health Tech: Hims earnings, Omada's PBM strategy, and the uphill battle faced by new sepsis algorithms.

STAT examines America's failure to address excessive alcohol use across decades.

(MedPage Today) -- Note that some links may require registration or subscription. Spring & Mulberry expanded its voluntary recall of select chocolate bars because of possible Salmonella risk, the FDA posted. While HHS Secretary Robert F...